| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 26.162 | 75.628 | 90.084 | 88.247 |
| Total Income - EUR | - | - | - | - | 2 | 0 | 26.162 | 75.959 | 91.264 | 88.285 |
| Total Expenses - EUR | - | - | - | - | 1.232 | 10.005 | 20.879 | 29.485 | 53.951 | 62.505 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.229 | -10.005 | 5.283 | 46.474 | 37.313 | 25.780 |
| Net Profit/Loss - EUR | - | - | - | - | -1.229 | -10.005 | 4.498 | 44.195 | 36.401 | 23.131 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Vivanalexa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 99.607 | 903.563 | 898.185 | 829.348 | 790.412 |
| Current Assets | - | - | - | - | 17.414 | 43.718 | 42.754 | 29.901 | 26.690 | 23.162 |
| Inventories | - | - | - | - | 6.506 | 7.165 | 7.006 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 10.706 | 12.004 | 12.740 | 18.301 | 6.437 |
| Cash | - | - | - | - | 10.908 | 25.847 | 23.744 | 17.161 | 8.389 | 16.725 |
| Shareholders Funds | - | - | - | - | -913 | -10.901 | -6.161 | 38.015 | 10.094 | 6.649 |
| Social Capital | - | - | - | - | 316 | 310 | 303 | 304 | 303 | 302 |
| Debts | - | - | - | - | 27.899 | 154.226 | 952.478 | 890.071 | 845.944 | 806.924 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7739 - 7739" | |||||||||
| CAEN Financial Year |
7739
|
|||||||||
Comments - Vivanalexa S.r.l.